Net profit of Godavari Drugs rose 100.00% to Rs 2.66 crore in the quarter ended March 2024 as against Rs 1.33 crore during the previous quarter ended March 2023. Sales rose 3.40% to Rs 38.64 crore in the quarter ended March 2024 as against Rs 37.37 crore during the previous quarter ended March 2023.For the full year,net profit rose 46.44% to Rs 5.55 crore in the year ended March 2024 as against Rs 3.79 crore during the previous year ended March 2023. Sales declined 1.82% to Rs 156.71 crore in the year ended March 2024 as against Rs 159.62 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales38.6437.37 3 156.71159.62 -2 OPM %11.577.17 -8.496.22 - PBDT3.351.81 85 9.006.65 35 PBT2.821.31 115 7.014.71 49 NP2.661.33 100 5.553.79 46 Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Net profit of Godavari Drugs rose 82.09% to Rs 1.22 crore in the quarter ended December 2023 as against Rs 0.67 crore during the previous quarter ended December 2022. Sales rose 10.09% to Rs 43.11 crore in the quarter ended December 2023 as against Rs 39.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales43.1139.16 10 OPM %8.175.80 - PBDT2.301.47 56 PBT1.800.96 88 NP1.220.67 82 Powered by Capital Market - Live News

Godavari Drugs has revised the meeting of the Board of Directors which was scheduled to be held on 14 February 2024. The meeting will now be held on 13 February 2024.Powered by Capital Market - Live News

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News